LOGO
LOGO

Quick Facts

Oshkosh Corp. Q2 Profit Up; Raises FY13 EPS Outlook

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024

Oshkosh Corporation, (OSK), a manufacturer of specialty vehicles and vehicle bodies, Tuesday reported a higher net income for the second quarter, in spite of lower revenues. The firm also raised its full-year earnings guidance.

For the quarter, the company reported net income from continuing operations of $85.4 million or $0.96 per share compared with $42.8 million or $0.47 per share during corresponding quarter last year. Including the discontinued operations, the company reported net income of $0.97 per share. On average, eleven analysts polled by Thomson Reuters expected earnings per share of $0.89 for the quarter. Analysts' estimates typically exclude one-time items.

Net sales for the second quarter were $1.98 billion, a 3.8 percent decline from $2.06 billion generated during the comparable period. Analysts estimated the company to report revenues of $2.02 billion. Higher sales in all non-defense segments were not sufficient to offset an expected decline in defense segment sales, the company said in a statement.

The firm raised its full-year earnings per share estimate to $2.90 - $3.15 from prior projected range of $2.80 - $3.05. The Street expects the company to report earnings of $3.06 per share.

For comments and feedback contact: editorial@rttnews.com

Business News

Global Economics Weekly Update - Jun 01 - Jun 05, 2026

June 05, 2026 16:18 ET
A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.

RELATED NEWS
Latest Updates on COVID-19